Therapy News and Research

RSS

Cancer-causing gene also plays a crucial role in aging, study finds

A gene called Myc (pronounced "mick") that is among the most important drivers of cancer in both mice and humans also plays a newly discovered crucial role in aging, according to a new Cell Reports study by researchers at UPMC Children's Hospital of Pittsburgh and the University of Pittsburgh School of Medicine.

24 Jul 2023

New AI-based system aims to facilitate the rehabilitation process for stroke patients

Statistics indicate that globally 1 in 4 adults over the age of 25 will have a stroke in their lifetime. One of the most serious consequences of this disease is disability.

24 Jul 2023

New technique can make radiation therapy safer for patients with prostate cancer

A technique that uses imaging technology as a guide can make radiation therapy safer for patients with prostate cancer by helping clinicians accurately aim radiation beams at the prostate while avoiding nearby tissue in the bladder, urethra, and rectum.

24 Jul 2023

Could alpha lipoic acid treat polycystic ovary syndrome?

Authors analyzed the efficacy of alpha lipoic acid (ALA) in treating polycystic ovary syndrome (PCOS).

24 Jul 2023

Do probiotics supplements really make a difference during antibiotic treatment? Probably not, says research

Researchers evaluated previous work conducting controlled trials of patients undergoing antibiotic therapy.

24 Jul 2023

Exclusion of chronic kidney disease patients from cardiovascular trials leaves significant evidence gaps

Study looks at how and where patients with CKD have been excluded from CVD RCTs over the last two decades.

24 Jul 2023

HIV-positive people with low-level viral load pose ‘almost zero’ risk to sexual partners

People living with HIV who maintain low – but still detectible – levels of the virus and adhere to their antiretroviral regimen have almost zero risk of transmitting it to their sexual partners, according to an analysis published in The Lancet.

23 Jul 2023

Phenotype-based approach to obesity treatment shows promise

In a pilot study of 165 people, Mayo Clinic researchers looked at the effectiveness of two different approaches to weight loss: a standard lifestyle intervention and individualized therapy.

21 Jul 2023

Extracellular vesicles may drive fibrosis in scleroderma

Extracellular vesicles, responsible for cell-to-cell communication, might be a driver of fibrosis in systemic sclerosis, according to a recent paper in Arthritis and Rheumatology.

21 Jul 2023

Hundreds of proteins and mRNA molecules mislocated in ALS nerve cells

Researchers at the Francis Crick Institute and UCL have shown that hundreds of proteins and mRNA molecules are found in the wrong place in nerve cells affected by Motor Neuron Disease (MND), also known as Amyotrophic Lateral Sclerosis (ALS).

21 Jul 2023

Using bacteriophages to treat bladder infections

About one in two women are affected by cystitis during her lifetime, and many suffer from recurrent urinary tract infections.

21 Jul 2023

KIPA shows promise in predicting chemotherapy response in triple negative breast cancer

Researchers at Baylor College of Medicine and collaborating institutions are developing a strategy to predict the response of triple negative breast cancer (TNBC) to chemotherapy, which would be a valuable tool for physicians deciding on the treatment with better probability of success on an individual basis.

21 Jul 2023

ARMGO Pharma Enrolls First Patient in Phase 2 Trial of ARM210 for the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia

Trial to investigate the safety and efficacy of ARM210 for the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT).

21 Jul 2023

Unchained Labs goes all in on Lipid Nanoparticles, acquires Blacktrace Holdings

Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tools for the job, acquired Blacktrace Holdings today.

From Unchained Labs 21 Jul 2023

Advancing vaccine adjuvants: exploring cutting-edge platforms for improved immunization

A group of authors summarized adjuvant mechanisms, characteristics, and applications, seeking to overcome current vaccine limitations.

21 Jul 2023

ECOG-ACRIN launches new trial to evaluate nilotinib and paclitaxel for advanced cancers

The ECOG-ACRIN Cancer Research Group has enrolled the first patient in a new treatment trial to evaluate the effectiveness of adding nilotinib to standard paclitaxel chemotherapy.

20 Jul 2023

Catheter ablation: A new first-line treatment option for atrial fibrillation

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Atrial fibrillation is the most common arrhythmia worldwide, affecting millions of the general population.

20 Jul 2023

Researchers develop novel system to identify new therapeutics for familial hypercholesterolemia

The Mona Lisa, painted by the Italian artist Leonardo da Vinci, is one of the most recognizable paintings in the world. But many people would be surprised to learn that this painting offers the first evidence of a disease called familial hypercholesterolemia (FH).

20 Jul 2023

Six new Damon Runyon Clinical Investigators announced for 2023

The Damon Runyon Cancer Research Foundation has named six new Damon Runyon Clinical Investigators.

20 Jul 2023

Understanding persistent COVID-19 symptoms: study explores early indicators of long COVID

Researchers investigated early biomarkers of post-acute sequelae of SARS-CoV-2 infection in individuals intensively sampled during the acute phase of COVID-19.

20 Jul 2023

Therapy News and Research

Cancer-causing gene also plays a crucial role in aging, study finds

New AI-based system aims to facilitate the rehabilitation process for stroke patients

New technique can make radiation therapy safer for patients with prostate cancer

Could alpha lipoic acid treat polycystic ovary syndrome?

Do probiotics supplements really make a difference during antibiotic treatment? Probably not, says research

Exclusion of chronic kidney disease patients from cardiovascular trials leaves significant evidence gaps

HIV-positive people with low-level viral load pose ‘almost zero’ risk to sexual partners

Phenotype-based approach to obesity treatment shows promise

Extracellular vesicles may drive fibrosis in scleroderma

Hundreds of proteins and mRNA molecules mislocated in ALS nerve cells

Using bacteriophages to treat bladder infections

KIPA shows promise in predicting chemotherapy response in triple negative breast cancer

ARMGO Pharma Enrolls First Patient in Phase 2 Trial of ARM210 for the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia

Unchained Labs goes all in on Lipid Nanoparticles, acquires Blacktrace Holdings

Advancing vaccine adjuvants: exploring cutting-edge platforms for improved immunization

ECOG-ACRIN launches new trial to evaluate nilotinib and paclitaxel for advanced cancers

Catheter ablation: A new first-line treatment option for atrial fibrillation

Researchers develop novel system to identify new therapeutics for familial hypercholesterolemia

Six new Damon Runyon Clinical Investigators announced for 2023

Understanding persistent COVID-19 symptoms: study explores early indicators of long COVID

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News